Alternatives to Adaptyv Biosystems

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Advancing next-generation mRNA medicines.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

AI-enabled technology for cell biology research and biopharma development.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Global supplier of life science research tools, including antibodies, reagents, and assays.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A global leader in clinical pharmacology and bioanalytical sciences.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

AI-powered knowledge discovery for life sciences.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Developing oral small molecule medicines for immunological and chronic diseases.

Pioneering vision restoration therapies for severe retinal degenerations.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing novel therapies to reverse aging and extend lifespan.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

A biotechnology company focused on oncology drug discovery.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Scalable, one-time curative in-vivo gene editing therapies.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Platform designed to cut cell and gene therapy production costs.

Develops and distributes bioreactor technology for stem cell cultivation.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

AI-powered platform for designing novel molecular structures for new medicines.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Developing disease-responsive advanced therapies through programmable gene control technology.

Developing human microbiology models for drug discovery.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Developing breath-based diagnostics for lung diseases.

Life science company pioneering drug discovery with AI and advanced technologies.